MedPath
NMPA Approval

Octreotide Acetate Injection

国药准字HJ20140908

September 30, 2024

H20140908

Drug Information

醋酸奥曲肽注射液

启文

注射剂

1ml:0.1mg(按C₄₉H₆₆N₁₀O₁₀S₂计)

化学药品

September 30, 2024

September 29, 2029

Company Information

Applicant Company

Halol-Baroda Highway, Halol-389 350, Dist: Panchmahal, Gujarat State, India.

Manufacturing Company

Halol-Baroda Highway, Halol-389 350, Dist: Panchmahal, Gujarat State, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

醋酸奥曲肽注射液 - NMPA 批准文号 | MedPath